News
Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.
Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results